Skip to main content
. 2019 Jul 12;52(1):263–276. doi: 10.4143/crt.2019.192

Fig. 1.

Fig. 1.

Flow diagram summarizing the case selection procedure. PDNEC, poorly differentiated neuroendocrine carcinoma; H&E, hematoxylin and eosin; IHC, immunohistochemistry; PanNEN, pancreatic neuroendocrine neoplasm; PanNET, pancreatic neuroendocrine tumor; HPF, high-power field.